Molecular Mechanisms Involved in Podocyte EMT and Concomitant Diabetic Kidney Diseases: an Update

Overview

Journal Ren Fail

Publisher Informa Healthcare

Date 2017 Apr 18

PMID 28413908

Citations 60

Authors

Qidi Ying

Guanzhong Wu

Affiliations

Soon will be listed here.

Abstract

Epithelial-mesenchymal transition (EMT) is a tightly regulated process by which epithelial cells lose their hallmark epithelial characteristics and gain the features of mesenchymal cells. For podocytes, expression of nephrin, podocin, P-cadherin, and ZO-1 is downregulated, the slit diaphragm (SD) will be altered, and the actin cytoskeleton will be rearranged. Diabetes, especially hyperglycemia, has been demonstrated to incite podocyte EMT through several molecular mechanisms such as TGF-β/Smad classic pathway, Wnt/β-catenin signaling pathway, Integrins/integrin-linked kinase (ILK) signaling pathway, MAPKs signaling pathway, Jagged/Notch signaling pathway, and NF-κB signaling pathway. As one of the most fundamental prerequisites to develop ground-breaking therapeutic options to prevent the development and progression of diabetic kidney disease (DKD), a comprehensive understanding of the molecular mechanisms involved in the pathogenesis of podocyte EMT is compulsory. Therefore, the purpose of this paper is to update the research progress of these underlying signaling pathways and expound the podocyte EMT-related DKDs.

Citing Articles

Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic Nephropathy.

Shu J, Chen D, Chen W, Zhang X, Wang S, Chong N Diabetes Metab Syndr Obes. 2025; 18:637-651.

PMID: 40034482 PMC: 11874765. DOI: 10.2147/DMSO.S503133.

FSTL1 aggravates high glucose-induced oxidative stress and transdifferentiation in HK-2 cells.

Zhang B, Geng H, Zhao K, Omorou M, Liu S, Ye Z Sci Rep. 2025; 15(1):434.

PMID: 39748077 PMC: 11696259. DOI: 10.1038/s41598-024-84462-5.

Targeting Fibrosis: From Molecular Mechanisms to Advanced Therapies.

Di X, Li Y, Wei J, Li T, Liao B Adv Sci (Weinh). 2024; 12(3):e2410416.

PMID: 39665319 PMC: 11744640. DOI: 10.1002/advs.202410416.

Urolithin A Ameliorates the TGF Beta-Dependent Impairment of Podocytes Exposed to High Glucose.

Lewko B, Wodzinska M, Daca A, Ploska A, Obremska K, Kalinowski L J Pers Med. 2024; 14(9).

PMID: 39338168 PMC: 11433157. DOI: 10.3390/jpm14090914.

Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review).

Qu P, Li L, Jin Q, Liu D, Qiao Y, Zhang Y Int J Mol Med. 2024; 54(5).

PMID: 39301658 PMC: 11414529. DOI: 10.3892/ijmm.2024.5428.

References

Alcorn J, Guala A, van der Velden J, McElhinney B, Irvin C, Davis R . Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci. 2008; 121(Pt 7):1036-45. PMC: 2876720. DOI: 10.1242/jcs.019455. View

Dennler S, Itoh S, Vivien D, Ten Dijke P, Huet S, Gauthier J . Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998; 17(11):3091-100. PMC: 1170648. DOI: 10.1093/emboj/17.11.3091. View

Hwang I, Seo E, Ha H . Wnt/beta-catenin signaling: a novel target for therapeutic intervention of fibrotic kidney disease. Arch Pharm Res. 2010; 32(12):1653-62. DOI: 10.1007/s12272-009-2200-3. View

Miele L . Notch signaling. Clin Cancer Res. 2006; 12(4):1074-9. DOI: 10.1158/1078-0432.CCR-05-2570. View

Hoberg J, Popko A, Ramsey C, Mayo M . IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol. 2005; 26(2):457-71. PMC: 1346914. DOI: 10.1128/MCB.26.2.457-471.2006. View

Niu H, Nie L, Liu M, Chi Y, Zhang T, Li Y . Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells. BMC Nephrol. 2014; 15:135. PMC: 4151867. DOI: 10.1186/1471-2369-15-135. View

Lin C, Wang F, Hsu Y, Chen C, Tseng M, Saleem M . Modulation of notch-1 signaling alleviates vascular endothelial growth factor-mediated diabetic nephropathy. Diabetes. 2010; 59(8):1915-25. PMC: 2911050. DOI: 10.2337/db09-0663. View

Hannigan G, Troussard A, Dedhar S . Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer. 2005; 5(1):51-63. DOI: 10.1038/nrc1524. View

Lee Y, Kwon Y, Joo C . Integrin-linked kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun. 2004; 316(4):997-1001. DOI: 10.1016/j.bbrc.2004.02.150. View

10.

Kretzler M, Teixeira V, Unschuld P, Cohen C, Wanke R, Edenhofer I . Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J. 2001; 15(10):1843-5. DOI: 10.1096/fj.00-0832fje. View

11.

Yang J, Zhang X, Li Y, Liu Y . Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling. J Am Soc Nephrol. 2003; 14(12):3167-77. DOI: 10.1097/01.asn.0000099373.33259.b2. View

12.

Welsh G, Saleem M . The podocyte cytoskeleton--key to a functioning glomerulus in health and disease. Nat Rev Nephrol. 2011; 8(1):14-21. DOI: 10.1038/nrneph.2011.151. View

13.

Sonnylal S, Shi-Wen X, Leoni P, Naff K, Van Pelt C, Nakamura H . Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 2010; 62(5):1523-32. PMC: 3866029. DOI: 10.1002/art.27382. View

14.

Schinner S, Willenberg H, Schott M, Scherbaum W . Pathophysiological aspects of Wnt-signaling in endocrine disease. Eur J Endocrinol. 2009; 160(5):731-7. DOI: 10.1530/EJE-08-0831. View

15.

Collu G, Brennan K . Cooperation between Wnt and Notch signalling in human breast cancer. Breast Cancer Res. 2007; 9(3):105. PMC: 1929088. DOI: 10.1186/bcr1671. View

16.

Sharma M, Callen S, Zhang D, Singhal P, Vanden Heuvel G, Buch S . Activation of Notch signaling pathway in HIV-associated nephropathy. AIDS. 2010; 24(14):2161-70. PMC: 3086691. DOI: 10.1097/QAD.0b013e32833dbc31. View

17.

Naves M, Requiao-Moura L, Soares M, Silva-Junior J, Mastroianni-Kirsztajn G, Teixeira V . Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis. J Nephrol. 2011; 25(3):401-9. DOI: 10.5301/jn.5000017. View

18.

Chen X, Ren Z, Liang W, Zha D, Liu Y, Chen C . c-Abl mediates angiotensin II-induced apoptosis in podocytes. J Mol Histol. 2013; 44(5):597-608. PMC: 3758790. DOI: 10.1007/s10735-013-9505-8. View

19.

Pavenstadt H, Kriz W, Kretzler M . Cell biology of the glomerular podocyte. Physiol Rev. 2002; 83(1):253-307. DOI: 10.1152/physrev.00020.2002. View

20.

Li C, Siragy H . High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-β-catenin-snail signaling pathway. PLoS One. 2014; 9(2):e89233. PMC: 3923071. DOI: 10.1371/journal.pone.0089233. View